How much revenue did Biohit Oyj generate this year?
Biohit Oyj has achieved a revenue of 15.45 M EUR this year.
Biohit Oyj Revenue 2024
Biohit Oyj Revenue
15.45 M EUR
Ticker
BIOBV.HE
ISIN
FI0009005482
In 2024, Biohit Oyj's sales reached 15.45 M EUR, a 18.16% difference from the 13.08 M EUR sales recorded in the previous year.
The Biohit Oyj Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2027e | 23.83 | 35,52 |
| 2026e | 20.6 | 41,09 |
| 2025e | 17.51 | 48,34 |
| 2024e | 15.45 | 54,78 |
| 2023 | 13.08 | 64,73 |
| 2022 | 10.95 | 64,94 |
| 2021 | 9.36 | 63,19 |
| 2020 | 7.12 | 55,57 |
| 2019 | 10.05 | 66,33 |
| 2018 | 9.93 | 64,86 |
| 2017 | 8.98 | 62,81 |
| 2016 | 8.2 | 51,31 |
| 2015 | 6.05 | 52,82 |
| 2014 | 4.36 | 55,90 |
| 2013 | 3.45 | 50,72 |
| 2012 | 2.05 | 35,61 |
| 2011 | 2.1 | 53,81 |
| 2010 | 40.26 | 79,63 |
| 2009 | 35.53 | 81,00 |
| 2008 | 35.27 | 80,24 |
| 2007 | 32.83 | 79,59 |
| 2006 | 31.44 | 79,55 |
| 2005 | 28.73 | 80,19 |
| 2004 | 26.88 | 79,24 |
Biohit Oyj Revenue, EBIT, Net Income FI0009005482 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Biohit Oyj, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biohit Oyj from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biohit Oyj’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Biohit Oyj. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Biohit Oyj’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Biohit Oyj’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biohit Oyj’s growth potential.
Biohit Oyj Revenue, EBIT and net profit per share
| Date | Biohit Oyj Revenue | Biohit Oyj EBIT | Biohit Oyj Net Income |
|---|---|---|---|
| 2027e | 23.83 M undefined | 3.51 M undefined | 2.34 M undefined |
| 2026e | 20.6 M undefined | 3.09 M undefined | 2.01 M undefined |
| 2025e | 17.51 M undefined | 2.06 M undefined | 1.63 M undefined |
| 2024e | 15.45 M undefined | 2.06 M undefined | 1.63 M undefined |
| 2023 | 13.08 M undefined | 1.83 M undefined | 1.85 M undefined |
| 2022 | 10.95 M undefined | 1.13 M undefined | 601,000 undefined |
| 2021 | 9.36 M undefined | -1.48 M undefined | -1.5 M undefined |
| 2020 | 7.12 M undefined | -3.17 M undefined | -3.31 M undefined |
| 2019 | 10.05 M undefined | -1.41 M undefined | -1.42 M undefined |
| 2018 | 9.93 M undefined | -1.97 M undefined | -2.14 M undefined |
| 2017 | 8.98 M undefined | -1.63 M undefined | 6.14 M undefined |
| 2016 | 8.2 M undefined | -3.16 M undefined | -3.3 M undefined |
| 2015 | 6.05 M undefined | -2.83 M undefined | -2.92 M undefined |
| 2014 | 4.36 M undefined | -4.5 M undefined | -1.16 M undefined |
| 2013 | 3.45 M undefined | -5.86 M undefined | -5.92 M undefined |
| 2012 | 2.05 M undefined | -4.59 M undefined | -3.66 M undefined |
| 2011 | 2.1 M undefined | -2.21 M undefined | 37.71 M undefined |
| 2010 | 40.26 M undefined | 510,000 undefined | 60,000 undefined |
| 2009 | 35.53 M undefined | 1.19 M undefined | 390,000 undefined |
| 2008 | 35.27 M undefined | 1.31 M undefined | 900,000 undefined |
| 2007 | 32.83 M undefined | -480,000 undefined | -1.5 M undefined |
| 2006 | 31.44 M undefined | -140,000 undefined | -840,000 undefined |
| 2005 | 28.73 M undefined | -30,000 undefined | -230,000 undefined |
| 2004 | 26.88 M undefined | -170,000 undefined | -590,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 26.88 M EUR | -170,000 EUR | -590,000 EUR |
| 2005 | 28.73 M EUR | -30,000 EUR | -230,000 EUR |
| 2006 | 31.44 M EUR | -140,000 EUR | -840,000 EUR |
| 2007 | 32.83 M EUR | -480,000 EUR | -1.5 M EUR |
| 2008 | 35.27 M EUR | 1.31 M EUR | 900,000 EUR |
| 2009 | 35.53 M EUR | 1.19 M EUR | 390,000 EUR |
| 2010 | 40.26 M EUR | 510,000 EUR | 60,000 EUR |
| 2011 | 2.1 M EUR | -2.21 M EUR | 37.71 M EUR |
| 2012 | 2.05 M EUR | -4.59 M EUR | -3.66 M EUR |
| 2013 | 3.45 M EUR | -5.86 M EUR | -5.92 M EUR |
| 2014 | 4.36 M EUR | -4.5 M EUR | -1.16 M EUR |
| 2015 | 6.05 M EUR | -2.83 M EUR | -2.92 M EUR |
| 2016 | 8.2 M EUR | -3.16 M EUR | -3.3 M EUR |
| 2017 | 8.98 M EUR | -1.63 M EUR | 6.14 M EUR |
| 2018 | 9.93 M EUR | -1.97 M EUR | -2.14 M EUR |
| 2019 | 10.05 M EUR | -1.41 M EUR | -1.42 M EUR |
| 2020 | 7.12 M EUR | -3.17 M EUR | -3.31 M EUR |
| 2021 | 9.36 M EUR | -1.48 M EUR | -1.5 M EUR |
| 2022 | 10.95 M EUR | 1.13 M EUR | 601,000 EUR |
| 2023 | 13.08 M EUR | 1.83 M EUR | 1.85 M EUR |
| 2024e | 15.45 M EUR | 2.06 M EUR | 1.63 M EUR |
| 2025e | 17.51 M EUR | 2.06 M EUR | 1.63 M EUR |
| 2026e | 20.6 M EUR | 3.09 M EUR | 2.01 M EUR |
| 2027e | 23.83 M EUR | 3.51 M EUR | 2.34 M EUR |
Biohit Oyj stock margins FI0009005482 ·
The Biohit Oyj margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biohit Oyj. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biohit Oyj.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Biohit Oyj's sales revenue. A higher gross margin percentage indicates that the Biohit Oyj retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Biohit Oyj's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Biohit Oyj's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biohit Oyj's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biohit Oyj. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biohit Oyj's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Biohit Oyj Margin History
| Biohit Oyj Gross margin | Biohit Oyj Profit margin | Biohit Oyj EBIT margin | Biohit Oyj Profit margin |
|---|---|---|---|
| 2027e | 64.73 % | 14.73 % | 9.81 % |
| 2026e | 64.73 % | 15 % | 9.77 % |
| 2025e | 64.73 % | 11.76 % | 9.34 % |
| 2024e | 64.73 % | 13.33 % | 10.58 % |
| 2023 | 64.73 % | 13.96 % | 14.16 % |
| 2022 | 64.94 % | 10.31 % | 5.49 % |
| 2021 | 63.19 % | -15.81 % | -16.02 % |
| 2020 | 55.57 % | -44.56 % | -46.51 % |
| 2019 | 66.33 % | -14.05 % | -14.1 % |
| 2018 | 64.86 % | -19.79 % | -21.58 % |
| 2017 | 62.81 % | -18.12 % | 68.37 % |
| 2016 | 51.31 % | -38.54 % | -40.21 % |
| 2015 | 52.82 % | -46.77 % | -48.21 % |
| 2014 | 55.9 % | -103.21 % | -26.61 % |
| 2013 | 50.72 % | -169.86 % | -171.59 % |
| 2012 | 35.61 % | -223.9 % | -178.54 % |
| 2011 | 53.81 % | -105.24 % | 1,795.71 % |
| 2010 | 79.63 % | 1.27 % | 0.15 % |
| 2009 | 81 % | 3.35 % | 1.1 % |
| 2008 | 80.24 % | 3.71 % | 2.55 % |
| 2007 | 79.59 % | -1.46 % | -4.57 % |
| 2006 | 79.55 % | -0.45 % | -2.67 % |
| 2005 | 80.19 % | -0.1 % | -0.8 % |
| 2004 | 79.24 % | -0.63 % | -2.19 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 79.24 % | -0.63 % | -2.19 % |
| 2005 | 80.19 % | -0.1 % | -0.8 % |
| 2006 | 79.55 % | -0.45 % | -2.67 % |
| 2007 | 79.59 % | -1.46 % | -4.57 % |
| 2008 | 80.24 % | 3.71 % | 2.55 % |
| 2009 | 81 % | 3.35 % | 1.1 % |
| 2010 | 79.63 % | 1.27 % | 0.15 % |
| 2011 | 53.81 % | -105.24 % | 1,795.71 % |
| 2012 | 35.61 % | -223.9 % | -178.54 % |
| 2013 | 50.72 % | -169.86 % | -171.59 % |
| 2014 | 55.9 % | -103.21 % | -26.61 % |
| 2015 | 52.82 % | -46.77 % | -48.21 % |
| 2016 | 51.31 % | -38.54 % | -40.21 % |
| 2017 | 62.81 % | -18.12 % | 68.37 % |
| 2018 | 64.86 % | -19.79 % | -21.58 % |
| 2019 | 66.33 % | -14.05 % | -14.1 % |
| 2020 | 55.57 % | -44.56 % | -46.51 % |
| 2021 | 63.19 % | -15.81 % | -16.02 % |
| 2022 | 64.94 % | 10.31 % | 5.49 % |
| 2023 | 64.73 % | 13.96 % | 14.16 % |
| 2024e | 64.73 % | 13.33 % | 10.58 % |
| 2025e | 64.73 % | 11.76 % | 9.34 % |
| 2026e | 64.73 % | 15 % | 9.77 % |
| 2027e | 64.73 % | 14.73 % | 9.81 % |
Biohit Oyj Aktienanalyse
What does Biohit Oyj do?
Biohit Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Biohit Oyj's Sales Figures
The sales figures of Biohit Oyj originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Biohit Oyj’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Biohit Oyj's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Biohit Oyj’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Biohit Oyj stock
How much was the turnover of the company Biohit Oyj compared to the previous year?
The revenue of Biohit Oyj has increased by 18.16% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Biohit Oyj?
The revenue of Biohit Oyj is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Biohit Oyj measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Biohit Oyj so important for investors?
The revenue of Biohit Oyj is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Biohit Oyj pay?
Over the past 12 months, Biohit Oyj paid a dividend of 0.72 EUR . This corresponds to a dividend yield of about 32.44 %. For the coming 12 months, Biohit Oyj is expected to pay a dividend of 0 EUR.
What is the dividend yield of Biohit Oyj?
The current dividend yield of Biohit Oyj is 32.44 %.
When does Biohit Oyj pay dividends?
Biohit Oyj pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biohit Oyj?
Biohit Oyj paid dividends every year for the past 0 years.
What is the dividend of Biohit Oyj?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biohit Oyj located?
Biohit Oyj is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biohit Oyj kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biohit Oyj from 4/28/2014 amounting to 0.723 EUR, you needed to have the stock in your portfolio before the ex-date on 4/15/2014.
When did Biohit Oyj pay the last dividend?
The last dividend was paid out on 4/28/2014.
What was the dividend of Biohit Oyj in the year 2023?
In the year 2023, Biohit Oyj distributed 0 EUR as dividends.
In which currency does Biohit Oyj pay out the dividend?
The dividends of Biohit Oyj are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biohit Oyj
Our stock analysis for Biohit Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biohit Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.